Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Aug 25;14(8):e244233.
doi: 10.1136/bcr-2021-244233.

Uterine leiomyosarcoma: a rare clinical entity

Affiliations
Case Reports

Uterine leiomyosarcoma: a rare clinical entity

Louise Dunphy et al. BMJ Case Rep. .

Abstract

Leiomyosarcoma is a rare aggressive malignant mesenchymal tumour, accounting for 1% of all uterine malignancies. It spreads rapidly through the intraperitoneal and haematogenous pathways. It is often diagnosed postoperatively following myomectomy, hysterectomy or supracervical hysterectomy for presumed benign disease. It has a predilection for perimenopausal women with a median age of 50 years. Individuals may describe symptoms of vaginal or abdominal pressure. Physical examination may reveal a large palpable pelvic mass, which may haemorrhage. Surgery remains the mainstay of treatment. Hysterectomy and a bilateral salpingo-oophorectomy may be considered, depending on the individual's menopausal status. Ovarian preservation can be considered in young patients. Adjuvant systemic treatment and radiotherapy are of no benefit. Gemcitabine/docetaxel and doxorubicin have shown benefit in the treatment of advanced or recurrent disease. The authors present the case of a 44-year-old woman with lower abdominal pain, vaginal bleeding and a uterine fibroid. Laboratory investigations confirmed a leucocytosis, neutrophilia and a thrombocythaemia. Further investigation with an MRI pelvis showed a very large, heterogeneous, malignant appearing pelvic mass compressing the right ureter and it appeared uterine in nature. Her staging CT showed multiple lung metastases. The diagnosis of uterine leiomyosarcoma was subsequently established. Due to the aggressive behaviour of this sarcoma subtype, novel early detection strategies and targeted therapies are required.

Keywords: cancer - see oncology; gynecological cancer.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
There appeared to be a heterogeneous area within the posterior myometrium measuring 58×51×56 mm suggestive of a subserosal fibroid that appeared to impinge on the endometrium.
Figure 2
Figure 2
The posterior myometrium fibroid measured 71×58×68 mm. The fundal myometrium fibroid measured 64×76×52 mm. The appearances were suggestive of a degenerating fibroid.
Figure 3
Figure 3
Her chest radiograph showed multiple small nodular densities in both of her lungs. The differential diagnosis included multiple pulmonary nodules including tumour deposits, small abscesses and connective tissue diseases. L, left side; PA, posteroanterior.
Figure 4
Figure 4
Further investigation with a MRI pelvis demonstrated a huge heterogeneous mass measuring 21×15×19 cm, centred on and replacing the uterus and cervix was observed.
Figure 5
Figure 5
A staging CT chest, abdomen and pelvis showed a large mediastinal lymph node in the anterior mediastinum (8 mm) and a right pelvic nodal mass lesion (120×65 mm). A mixed solid cystic mass lesion within the uterus was observed.

References

    1. Prat J, Mbatani N. Uterine sarcomas. Int J Gynaecol Obstet 2015;131 Suppl 2:S105–10. 10.1016/j.ijgo.2015.06.006 - DOI - PubMed
    1. Giuntoli RL, Metzinger DS, DiMarco CS, et al. . Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 2003;89:40–69. 10.1016/s0090-8258(03)00137-9 - DOI - PubMed
    1. Prat J. Figo staging for uterine sarcomas. Int J Gynaecol Obstet 2009;104:177–8. 10.1016/j.ijgo.2008.12.008 - DOI - PubMed
    1. Oliva E, Carcangiu ML, Carinelli SG, et al. . Mesenchymal tumours [chapter 5: tumours of the uterine corpus]. In: WHO classification of tumours of female reproductive organs. 4th edn. Lyon: IARC, 2014: 135–47.
    1. Silverberg SG, Major FJ, Blessing JA, et al. . Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. a gynecologic Oncology group pathologic study of 203 cases. Int J Gynecol Pathol 1990;9:1–19. 10.1097/00004347-199001000-00001 - DOI - PubMed

Publication types